4//SEC Filing
Meeker David P 4
Accession 0001104659-24-026162
CIK 0001649904other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:03 PM ET
Size
10.1 KB
Accession
0001104659-24-026162
Insider Transaction Report
Form 4
Meeker David P
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-02-16+99,000→ 220,099 total - Award
Restricted Stock Units
2024-02-16+85,000→ 85,000 total→ Common Stock (85,000 underlying) - Award
Stock Option (Right to Buy)
2024-02-16+259,000→ 259,000 totalExercise: $49.23Exp: 2034-02-15→ Common Stock (259,000 underlying)
Footnotes (4)
- [F1]The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F3]The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.
- [F4]The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001385155
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 7:03 PM ET
- Size
- 10.1 KB